Copyright
©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 303-310
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.303
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.303
Table 1 Patient sex at birth for gout with and without a history of cirrhosis
Patients without cirrhosis, n = 1491829 | Patients with cirrhosis, n = 36948 | OR | 95%CI | P value | ||||
Percentage | n | Percentage | n | |||||
Sex at birth | Female | 33.17 | 494890 | 25.37 | 9372 | 0.685 | 0.669-0.701 | < 0.05 |
Male | 66.83 | 996939 | 74.63 | 27576 |
Table 2 Differences in age distribution among patients hospitalized for gout with and without a history of cirrhosis
Patients without cirrhosis | Patients with cirrhosis | Mean difference | 95%CI | P value | |||||
Mean | SD | SE mean | Mean | SD | SE mean | ||||
Age at admission (yr) | 70.37 | 13.53 | 0.011 | 66.21 | 12.33 | 0.064 | 4.167 ± 0.071 | 4.027-4.306 | < 0.05 |
Table 3 Racial characteristics in patients hospitalized for gout with and without a history of cirrhosis
Race | Patients without cirrhosis | Patients with cirrhosis | P value | ||
% | n | % | n | ||
Caucasian | 71.0 | 890040 | 69.1 | 22725 | < 0.05 |
Black | 18.6 | 233005 | 17.4 | 5723 | |
Hispanic | 4.4 | 55174 | 7.4 | 2426 | |
Asian or Pacific Islander | 3.6 | 45217 | 3.6 | 1184 | |
Native American | 0.3 | 4289 | 0.4 | 122 | |
Other | 2.0 | 25351 | 2.1 | 703 |
Table 4 Primary outcomes in gout among hospitalized patients with and without cirrhosis
Patients without cirrhosis | Patients with cirrhosis | OR | 95%CI | P value | AOR | ACI | Adjusted P value | |||
Percentage | n | Percentage | n | |||||||
Mortality | 2.03 | 30286 | 5.49 | 2029 | 2.804 | 2.678-2.937 | < 0.050 | 3.092 | 2.939-3.252 | < 0.05 |
Gout flare | 2.77 | 41282 | 2.89 | 1066 | 1.044 | 0.982-1.110 | 0. 171 | 0.816 | 0.765-0.871 | < 0.05 |
Tophi | 0.75 | 11202 | 0.97 | 358 | 1.293 | 1.164-1.438 | < 0.050 | 1.025 | 0.914-1.149 | 0.677 |
Uric acid nephrolithiasis | 0.02 | 374 | 0.02 | 9 | 0.972 | 0.502-1.882 | 0.932 | 1.037 | 0.530-2.030 | 0.915 |
Nephropathy | 0.02 | 283 | 0.01 | 5 | 0.713 | 0.295-1.727 | 0.452 | 0.548 | 0.223-1.346 | 0.19 |
Arthrocentesis | 2.45 | 36611 | 2.21 | 818 | 0.900 | 0.839-0.965 | < 0.050 | 0.741 | 0.686-0.800 | < 0.05 |
Joint injection | 0.72 | 10673 | 0.52 | 192 | 0.725 | 0.628-0.837 | < 0.050 | 0.713 | 0.610-0.833 | < 0.050 |
Septic Arthritis | 0.31 | 4637 | 0.31 | 114 | 0.993 | 0.824-1.196 | 0.939 | 0.997 | 0.821-1.211 | 0.977 |
- Citation: Khrais A, Kahlam A, Tahir A, Shaikh A, Ahlawat S. Outcomes of gout in patients with cirrhosis: A national inpatient sample-based study. World J Hepatol 2023; 15(2): 303-310
- URL: https://www.wjgnet.com/1948-5182/full/v15/i2/303.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i2.303